Macquarie Group LTD Adamas Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
N/A
-1,799,420 Closed
0 $0
Q1 2020

May 15, 2020
SELL
N/A
-367,996 Reduced 16.98%
1,799,420 $5.2 Million
Q4 2019

Feb 14, 2020
SELL
N/A
-93,262 Reduced 4.13%
2,167,416 $8.22 Million
Q3 2019

Nov 14, 2019
SELL
N/A
-151,480 Reduced 6.28%
2,260,678 $11.6 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-209,542 Reduced 7.99%
2,412,158 $15 Million
Q1 2019

May 15, 2019
SELL
N/A
-86,517 Reduced 3.19%
2,621,700 $18.6 Million
Q4 2018

Feb 15, 2019
BUY
N/A
923,099 Added 51.71%
2,708,217 $23.1 Million
Q3 2018

Nov 15, 2018
BUY
N/A
474,808 Added 36.24%
1,785,118 $35.7 Million
Q2 2018

Aug 14, 2018
BUY
N/A
145,412 Added 12.48%
1,310,310 $33.8 Million
Q1 2018

May 11, 2018
BUY
N/A
273,936 Added 30.75%
1,164,898 $27.8 Million
Q4 2017

Feb 15, 2018
BUY
N/A
139,934 Added 18.63%
890,962 $30.2 Million
Q3 2017

Nov 08, 2017
BUY
N/A
751,028
751,028 $15.9 Million

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email